Bosh sahifaDVA • NYSE
add
Davita Inc
151,85 $
Seans yopilganidan keyin:(0,00%)0,00
151,85 $
Yopilgan:24-apr, 17:57:32 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
155,03 $
Kunlik diapazon
149,99 $ - 154,45 $
Yillik diapazon
101,00 $ - 159,42 $
Bozor kapitalizatsiyasi
10,01 mlrd USD
Oʻrtacha hajm
797,21 ming
Narx/foyda
15,96
Dividend daromadliligi
-
Asosiy maydon
NYSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 3,62 mlrd | 9,87% |
Joriy xarajat | 659,06 mln | 11,97% |
Sof foyda | 234,22 mln | -9,68% |
Sof foyda marjasi | 6,47 | -17,79% |
Har bir ulushga tushum | 3,40 | 51,79% |
EBITDA | 737,91 mln | 12,69% |
Amaldagi soliq stavkasi | 20,05% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 700,74 mln | -17,17% |
Jami aktivlari | 17,48 mlrd | 1,13% |
Jami passivlari | 16,32 mlrd | 7,42% |
Umumiy kapital | 1,16 mlrd | — |
Tarqatilgan aksiyalar | 66,80 mln | — |
Narxi/balansdagi bahosi | -16,32 | — |
Aktivlardan daromad | 7,87% | — |
Kapitaldan daromad | 9,79% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 234,22 mln | -9,68% |
Operatsiyalardan naqd pul | 540,73 mln | -1,26% |
Sarmoyadan naqd pul | -163,13 mln | 34,22% |
Moliyadan naqd pul | -414,52 mln | 26,65% |
Naqd pulning sof oʻzgarishi | -37,67 mln | 86,49% |
Boʻsh pul | 395,96 mln | 16,37% |
Haqida
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500. Wikipedia
Tashkil etilgan
1992
Sayt
Xodimlar soni
78 000